Geron
GERN
#7211
Rank
โ‚น51.98 B
Marketcap
โ‚น80.69
Share price
-4.63%
Change (1 day)
-19.59%
Change (1 year)

EPS for Geron (GERN)

EPS in 2026 (TTM): -โ‚น7.32

According to Geron's latest financial reports the company's current EPS (TTM) is -โ‚น7.41. In 2025 the company made an earnings per share (EPS) of -โ‚น12.05 an increase over its 2024 EPS that were of -โ‚น25.02.

EPS history for Geron from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น7.32-39.22%
2025-โ‚น12.05-51.85%
2024-โ‚น25.02-18.18%
2023-โ‚น30.58-8.33%
2022-โ‚น33.36-0%
2021-โ‚น33.3633.33%
2020-โ‚น25.02-25%
2019-โ‚น33.36140%
2018-โ‚น13.90-16.67%
2017-โ‚น16.68-0%
2016-โ‚น16.68-1.2970366926827E+18%
2015โ‚น0.0000000000-100%
2014-โ‚น22.24
2012-โ‚น50.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น287.28 3,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น194.61-2,725.00%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น53.75 625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น108.42-1,562.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,714 36,512.50%๐Ÿ‡บ๐Ÿ‡ธ USA